Breast cancer hormone receptor testing in Asia: is it time to think again on expected positivity rates and methods of scoring?

Pathology. 2020 Apr;52(3):385-387. doi: 10.1016/j.pathol.2019.12.006. Epub 2020 Feb 24.

Authors

Anthony Rhodes¹, Kean-Hooi Teoh², Mee-Hoong See³, Kumar Ganesan², Lai-Meng Looi²

Affiliations

¹ Department of Pathology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. Electronic address: carhodes60@gmail.com.
² Department of Pathology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
³ Department of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

PMID: 32107079
DOI: 10.1016/j.pathol.2019.12.006

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Aged, 80 and over
Biomarkers, Tumor / analysis*
Breast Neoplasms*
Female
Humans
Malaysia
Middle Aged
Receptors, Estrogen / analysis*
Receptors, Progesterone / analysis*
Reference Values

Substances

Biomarkers, Tumor
Receptors, Estrogen
Receptors, Progesterone